Cbd Medic - Odor-free Serious Relief
FDA Label NDC 24909-721

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Aidance Skincare & Topical Solutions, Llc for the product Cbd Medic - Odor-free Serious Relief (NDC 24909-721). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, keep out of reach of children., directions, inactive ingredients, principal display panel - 30g size, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient

Lidocaine HCL 4%

Purpose

Lidocaine HCL - External Analgesic

Uses

Temporarily relieves minor pain.

Warnings

For external use only. Do not use on wounds or damaged skin. When using this product - avoid contact with eyes or mucous membranes - do not bandage tightly or use with heating pad. Stop use and ask a doctor if - condition worsens or symptoms persist for more than 7 days - symptoms clear up and occur again within a few days - excessive skin irritation develops.

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

Adults and children 12 years of age and older: Apply to affected area not more than 3 to 4 times daily. Children under 12 years of age: Ask a doctor.

Inactive Ingredients

Beeswax (organic), cotton seed oil, emulsifying wax, hemp extract, jojoba seed oil, magnesium oxide, purified water, shea butter, silver oxide, sorbic acid, zinc oxide.

Principal Display Panel - 30G Size

CBDMEDIC

ODOR-FREE
SERIOUS RELIEF
Revolutionary Pain Relief
Lidocaine 4%

Net WT 30g (1oz.)

Tube (Cbdmedic Odor Free Lido 040317)

Tube (Cbdmedic Odor Free Lido 040317)

* Please review the disclaimer below.